Skip to main content

Month: April 2020

Intellinetics, Inc. Acquires CEO Imaging Systems, Inc.

 Strengthens K-12 Market Penetration and Positions for Future GrowthCOLUMBUS, Ohio, April 24, 2020 (GLOBE NEWSWIRE) — Intellinetics, Inc., (OTCQB: INLX) a cloud-based document solutions provider, announced it has acquired substantially all the assets of CEO Imaging Systems, Inc., doing business as CEO Image Systems, a document solutions company that specializes in the K-12 education market, as well as financial services and others. Located in Plymouth, MI, CEO Imaging Systems had $0.5 million in revenues (unaudited) in its most recent fiscal year, ended December 31, 2019.The purchase of the CEO Imaging Systems business expands Intellinetics’ content management products and services to highly regulated, risk and compliance-intensive markets. The IntelliCloud™ solution suite can now be expanded to include the CEO Image Executive™...

Continue reading

Gulf & Pacific Equities Corp. reports on 2019 Year End Results with Revenue of $3,838,060

TORONTO, April 24, 2020 (GLOBE NEWSWIRE) — Gulf & Pacific Equities Corp. (TSX-V: GUF) an established company focused on the acquisition, management and development of anchored shopping centres in Western Canada, reports a 3.87% decrease in revenues to $3,838,060 in the year ended 2019 from $3,992,607 at same period last year.Details of the twelve and three months financial results for fiscal 2019 and 2018 under International Financial Reporting Standards (IFRS) as summarized below are also available at www.sedar.com or at the company’s website www.gpequities.com.About Gulf & Pacific Equities Corp.Gulf & Pacific Equities Corp. was incorporated under the laws of the Province of Alberta on April 8, 1998 and thereafter completed a public offering of common shares by prospectus dated June 26, 1998 (TSX-V: GUF).The Company acquires,...

Continue reading

KEMET Announces Completion of CFIUS Review

FORT LAUDERDALE, Fla., April 24, 2020 (GLOBE NEWSWIRE) — KEMET Corporation (“KEMET”) (NYSE: KEM) today announced that, in connection with the pending acquisition of KEMET by Yageo Corporation (“Yageo”) (TAIEX: 2327), on April 23, 2020, the Committee on Foreign Investment in the United States (CFIUS) notified the parties that it completed review of the pending acquisition of KEMET by Yageo and determined that there are no unresolved national security concerns with respect to the transaction.KEMET today also announced that, on April 15, 2020, the Taiwan Fair Trade Commission (TFTC) announced its approval of the acquisition of KEMET by Yageo. The parties continue to expect the transaction to close in the second half of 2020 with the goal of closing by the end of the third quarter of 2020, subject to additional customary closing conditions...

Continue reading

TRACON Pharmaceuticals Retains Global Rights to TRC253 Following Completion of a Phase 1/2 Trial

SAN DIEGO, April 24, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, today announced that it has retained global rights to and has sole responsibility for development and commercialization of TRC253 based on Janssen Pharmaceutica N.V.’s (Janssen’s) decision not to exercise its option to reacquire global rights to TRC253 following a review of the Phase 2 data in prostate cancer patients with acquired resistance to Xtandi® or Erleada®.  Under the original agreement, TRACON is obligated to make certain payments to Janssen if future development and regulatory milestones are achieved and to pay a royalty on net sales of TRC253.  TRACON has initiated an out-licensing process to identify a...

Continue reading

Surrey Bancorp Reports First Quarter Net Income of $1,056,012

MOUNT AIRY, N.C., April 24, 2020 (GLOBE NEWSWIRE) — Surrey Bancorp (the “Company”) (Pink Sheets: SRYB), the holding company for Surrey Bank & Trust (the “Bank”), today reported earnings for the first quarter of 2020.For the quarter ended March 31, 2020, net income totaled $1,056,012 or $0.25 per fully diluted common share, compared with $941,764 or $0.23 per fully diluted common share earned during the first quarter of 2019.Net interest income decreased from $3,246,223 in the first quarter of 2019 to $3,192,503 in 2020. The net interest margin decreased from 4.62 percent in the first quarter of 2019 to 4.19 percent in the first quarter of 2020 due to a general decrease in interest rates and a change in earning asset mix. Higher yielding loans made up 81.8 percent of average interest earning assets in the first quarter of 2019...

Continue reading

I-Mab Announces Upcoming Participation at May Conferences

SHANGHAI, China and ROCKVILLE, MD., April 24, 2020 (GLOBE NEWSWIRE) — I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders, today announced its participation in the following conferences in May. Details of the conferences and management presentation are as follows:Bank of America Securities Global Virtual Healthcare ConferencePresentation: Thursday, May 14, 2020 at 9:40-10:10 a.m. ETPresenters: Dr. Jingwu Zang, Founder, Honorary Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, and Ms. Leah Liu, Senior IR DirectorWebcast...

Continue reading

Alimera Sciences to Report First Quarter 2020 Financial Results on Wednesday, April 29, 2020 and Provide Corporate Update

ATLANTA, April 24, 2020 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces that it will report first quarter 2020 financial results on Wednesday, April 29, 2020 after the market close.Management will host a conference call at 9:00 AM ET on Thursday, April 30, 2020, to review financial results and provide an update on corporate developments.  Following management’s formal remarks, there will be a question and answer session.Participants are asked to pre-register for the call through the following link: http://dpregister.com/10142450. Please note that registered participants will receive their dial in number upon registration and will dial directly into the call without delay....

Continue reading

TELUS Friendly Future Foundation gives $250,000 to support homeless and marginalized citizens stay safe and cared for during COVID-19

VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) — The TELUS Friendly Future Foundation today announced a $250,000 donation to support a number of community healthcare leaders in their COVID-19 response for homeless and marginalized citizens across Canada. The funding will bolster efforts to provide a multitude of services, including COVID-19 assessments; triage service at temporary isolation shelters; and personal protective equipment and cleaning supplies to ensure a clean and safe environment for patients and clinicians. With the spread of COVID-19 persisting and more than 235,000 individuals experiencing homelessness in Canada each year, these services are crucial to help vulnerable populations through the pandemic.“During this global health emergency, our team’s unwavering commitment to helping those in our communities...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.